Lu NZ, Wardell SE, Burnstein KL, Defranco D, Fuller PJ, Giguere V, Hochberg RB, McKay L, Renoir JM, Weigel NL, Wilson EM, McDonnell DP, Cidlowski JA (2006). „International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors”. Pharmacol Revl58 (4): 782–97. DOI:10.1124/pr.58.4.9. PMID17132855. [Free full text]
Rhen T, Cidlowski JA (October 2005). „Antiinflammatory action of glucocorticoids--new mechanisms for old drugs”. N. Engl. J. Med.353 (16): 1711–23. DOI:10.1056/NEJMra050541. PMID16236742.
Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, Evans RM (1985). „Primary structure and expression of a functional human glucocorticoid receptor cDNA”. Nature318 (6047): 635–41. DOI:10.1038/318635a0. PMID2867473.
Kumar R, Thompson EB (2005). „Gene regulation by the glucocorticoid receptor: structure:function relationship”. J. Steroid Biochem. Mol. Biol.94 (5): 383–94. DOI:10.1016/j.jsbmb.2004.12.046. PMID15876404.
Pratt WB, Morishima Y, Murphy M, Harrell M (2006). „Chaperoning of glucocorticoid receptors”. Handb Exp Pharmacol172 (172): 111–38. DOI:10.1007/3-540-29717-0_5. PMID16610357.
Mendonca B, Leite M, de Castro M, Kino T, Elias L, Bachega T, Arnhold I, Chrousos G, Latronico A (2002). „Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene”. J Clin Endocrinol Metab87 (4): 1805–9. DOI:10.1210/jc.87.4.1805. PMID11932321.
Kullmann M, Schneikert J, Moll J, Heck S, Zeiner M, Gehring U, Cato AC (June 1998). „RAP46 is a negative regulator of glucocorticoid receptor action and hormone-induced apoptosis”. J. Biol. Chem.273 (23): 14620–5. DOI:10.1074/jbc.273.23.14620. PMID9603979.
Boruk M, Savory JG, Haché RJ (November 1998). „AF-2-dependent potentiation of CCAAT enhancer binding protein beta-mediated transcriptional activation by glucocorticoid receptor”. Mol. Endocrinol.12 (11): 1749–63. DOI:10.1210/me.12.11.1749. PMID9817600.
Almlöf T, Wallberg AE, Gustafsson JA, Wright AP (June 1998). „Role of important hydrophobic amino acids in the interaction between the glucocorticoid receptor tau 1-core activation domain and target factors”. Biochemistry37 (26): 9586–94. DOI:10.1021/bi973029x. PMID9649342.
Lin DY, Lai MZ, Ann DK, Shih HM (May 2003). „Promyelocytic leukemia protein (PML) functions as a glucocorticoid receptor co-activator by sequestering Daxx to the PML oncogenic domains (PODs) to enhance its transactivation potential”. J. Biol. Chem.278 (18): 15958–65. DOI:10.1074/jbc.M300387200. PMID12595526.
Jibard N, Meng X, Leclerc P, Rajkowski K, Fortin D, Schweizer-Groyer G, Catelli MG, Baulieu EE, Cadepond F (March 1999). „Delimitation of two regions in the 90-kDa heat shock protein (Hsp90) able to interact with the glucocorticosteroid receptor (GR)”. Exp. Cell Res.247 (2): 461–74. DOI:10.1006/excr.1998.4375. PMID10066374.
Kanelakis KC, Shewach DS, Pratt WB (September 2002). „Nucleotide binding states of hsp70 and hsp90 during sequential steps in the process of glucocorticoid receptor.hsp90 heterocomplex assembly”. J. Biol. Chem.277 (37): 33698–703. DOI:10.1074/jbc.M204164200. PMID12093808.
Hecht K, Carlstedt-Duke J, Stierna P, Gustafsson J, Brönnegârd M, Wikström AC (October 1997). „Evidence that the beta-isoform of the human glucocorticoid receptor does not act as a physiologically significant repressor”. J. Biol. Chem.272 (42): 26659–64. DOI:10.1074/jbc.272.42.26659. PMID9334248.
Stancato LF, Silverstein AM, Gitler C, Groner B, Pratt WB (April 1996). „Use of the thiol-specific derivatizing agent N-iodoacetyl-3-[125I]iodotyrosine to demonstrate conformational differences between the unbound and hsp90-bound glucocorticoid receptor hormone binding domain”. J. Biol. Chem.271 (15): 8831–6. DOI:10.1074/jbc.271.15.8831. PMID8621522.
Eggert M, Michel J, Schneider S, Bornfleth H, Baniahmad A, Fackelmayer FO, Schmidt S, Renkawitz R (November 1997). „The glucocorticoid receptor is associated with the RNA-binding nuclear matrix protein hnRNP U”. J. Biol. Chem.272 (45): 28471–8. DOI:10.1074/jbc.272.45.28471. PMID9353307.
Zilliacus J, Holter E, Wakui H, Tazawa H, Treuter E, Gustafsson JA (April 2001). „Regulation of glucocorticoid receptor activity by 14--3-3-dependent intracellular relocalization of the corepressor RIP140”. Mol. Endocrinol.15 (4): 501–11. DOI:10.1210/me.15.4.501. PMID11266503.
Subramaniam N, Treuter E, Okret S (June 1999). „Receptor interacting protein RIP140 inhibits both positive and negative gene regulation by glucocorticoids”. J. Biol. Chem.274 (25): 18121–7. DOI:10.1074/jbc.274.25.18121. PMID10364267.
Stevens A, Garside H, Berry A, Waters C, White A, Ray D (May 2003). „Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735”. Mol. Endocrinol.17 (5): 845–59. DOI:10.1210/me.2002-0320. PMID12569182.
Schulz M, Eggert M, Baniahmad A, Dostert A, Heinzel T, Renkawitz R (July 2002). „RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding”. J. Biol. Chem.277 (29): 26238–43. DOI:10.1074/jbc.M203268200. PMID12011091.
Kucera T, Waltner-Law M, Scott DK, Prasad R, Granner DK (July 2002). „A point mutation of the AF2 transactivation domain of the glucocorticoid receptor disrupts its interaction with steroid receptor coactivator 1”. J. Biol. Chem.277 (29): 26098–102. DOI:10.1074/jbc.M204013200. PMID12118039.
Bledsoe RK, Montana VG, Stanley TB, Delves CJ, Apolito CJ, McKee DD, Consler TG, Parks DJ, Stewart EL, Willson TM, Lambert MH, Moore JT, Pearce KH, Xu HE (July 2002). „Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition”. Cell110 (1): 93–105. DOI:10.1016/S0092-8674(02)00817-6. PMID12151000.
Préfontaine, G G; Walther R, Giffin W, Lemieux M E, Pope L, Haché R J (1999). „Selective binding of steroid hormone receptors to octamer transcription factors determines transcriptional synergism at the mouse mammary tumor virus promoter”. J. Biol. Chem. (UNITED STATES) 274 (38): 26713–9. DOI:10.1074/jbc.274.38.26713. ISSN0021-9258. PMID10480874.
Rao, Mira A; Cheng Helen, Quayle Alandra N, Nishitani Hideo, Nelson Colleen C, Rennie Paul S (December 2002). „RanBPM, a nuclear protein that interacts with and regulates transcriptional activity of androgen receptor and glucocorticoid receptor”. J. Biol. Chem. (United States) 277 (50): 48020–7. DOI:10.1074/jbc.M209741200. ISSN0021-9258. PMID12361945.
Caldenhoven E, Liden J, Wissink S, Van de Stolpe A, Raaijmakers J, Koenderman L, Okret S, Gustafsson JA, Van der Saag PT (April 1995). „Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids”. Mol. Endocrinol.9 (4): 401–12. DOI:10.1210/me.9.4.401. PMID7659084.
Li G, Wang S, Gelehrter TD (October 2003). „Identification of glucocorticoid receptor domains involved in transrepression of transforming growth factor-beta action”. J. Biol. Chem.278 (43): 41779–88. DOI:10.1074/jbc.M305350200. PMID12902338.
Zhang Z, Jones S, Hagood JS, Fuentes NL, Fuller GM (December 1997). „STAT3 acts as a co-activator of glucocorticoid receptor signaling”. J. Biol. Chem.272 (49): 30607–10. DOI:10.1074/jbc.272.49.30607. PMID9388192.
Stöcklin E, Wissler M, Gouilleux F, Groner B (October 1996). „Functional interactions between Stat5 and the glucocorticoid receptor”. Nature383 (6602): 726–8. DOI:10.1038/383726a0. PMID8878484.
Makino Y, Yoshikawa N, Okamoto K, Hirota K, Yodoi J, Makino I, Tanaka H (January 1999). „Direct association with thioredoxin allows redox regulation of glucocorticoid receptor function”. J. Biol. Chem.274 (5): 3182–8. DOI:10.1074/jbc.274.5.3182. PMID9915858.
Wakui H, Wright AP, Gustafsson J, Zilliacus J (March 1997). „Interaction of the ligand-activated glucocorticoid receptor with the 14-3-3 eta protein”. J. Biol. Chem.272 (13): 8153–6. DOI:10.1074/jbc.272.13.8153. PMID9079630.
nih.gov
ncbi.nlm.nih.gov
Lu NZ, Wardell SE, Burnstein KL, Defranco D, Fuller PJ, Giguere V, Hochberg RB, McKay L, Renoir JM, Weigel NL, Wilson EM, McDonnell DP, Cidlowski JA (2006). „International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors”. Pharmacol Revl58 (4): 782–97. DOI:10.1124/pr.58.4.9. PMID17132855. [Free full text]
Rhen T, Cidlowski JA (October 2005). „Antiinflammatory action of glucocorticoids--new mechanisms for old drugs”. N. Engl. J. Med.353 (16): 1711–23. DOI:10.1056/NEJMra050541. PMID16236742.
Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, Evans RM (1985). „Primary structure and expression of a functional human glucocorticoid receptor cDNA”. Nature318 (6047): 635–41. DOI:10.1038/318635a0. PMID2867473.
Kumar R, Thompson EB (2005). „Gene regulation by the glucocorticoid receptor: structure:function relationship”. J. Steroid Biochem. Mol. Biol.94 (5): 383–94. DOI:10.1016/j.jsbmb.2004.12.046. PMID15876404.
Pratt WB, Morishima Y, Murphy M, Harrell M (2006). „Chaperoning of glucocorticoid receptors”. Handb Exp Pharmacol172 (172): 111–38. DOI:10.1007/3-540-29717-0_5. PMID16610357.
Mendonca B, Leite M, de Castro M, Kino T, Elias L, Bachega T, Arnhold I, Chrousos G, Latronico A (2002). „Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene”. J Clin Endocrinol Metab87 (4): 1805–9. DOI:10.1210/jc.87.4.1805. PMID11932321.
Kullmann M, Schneikert J, Moll J, Heck S, Zeiner M, Gehring U, Cato AC (June 1998). „RAP46 is a negative regulator of glucocorticoid receptor action and hormone-induced apoptosis”. J. Biol. Chem.273 (23): 14620–5. DOI:10.1074/jbc.273.23.14620. PMID9603979.
Boruk M, Savory JG, Haché RJ (November 1998). „AF-2-dependent potentiation of CCAAT enhancer binding protein beta-mediated transcriptional activation by glucocorticoid receptor”. Mol. Endocrinol.12 (11): 1749–63. DOI:10.1210/me.12.11.1749. PMID9817600.
Almlöf T, Wallberg AE, Gustafsson JA, Wright AP (June 1998). „Role of important hydrophobic amino acids in the interaction between the glucocorticoid receptor tau 1-core activation domain and target factors”. Biochemistry37 (26): 9586–94. DOI:10.1021/bi973029x. PMID9649342.
Lin DY, Lai MZ, Ann DK, Shih HM (May 2003). „Promyelocytic leukemia protein (PML) functions as a glucocorticoid receptor co-activator by sequestering Daxx to the PML oncogenic domains (PODs) to enhance its transactivation potential”. J. Biol. Chem.278 (18): 15958–65. DOI:10.1074/jbc.M300387200. PMID12595526.
Jibard N, Meng X, Leclerc P, Rajkowski K, Fortin D, Schweizer-Groyer G, Catelli MG, Baulieu EE, Cadepond F (March 1999). „Delimitation of two regions in the 90-kDa heat shock protein (Hsp90) able to interact with the glucocorticosteroid receptor (GR)”. Exp. Cell Res.247 (2): 461–74. DOI:10.1006/excr.1998.4375. PMID10066374.
Kanelakis KC, Shewach DS, Pratt WB (September 2002). „Nucleotide binding states of hsp70 and hsp90 during sequential steps in the process of glucocorticoid receptor.hsp90 heterocomplex assembly”. J. Biol. Chem.277 (37): 33698–703. DOI:10.1074/jbc.M204164200. PMID12093808.
Hecht K, Carlstedt-Duke J, Stierna P, Gustafsson J, Brönnegârd M, Wikström AC (October 1997). „Evidence that the beta-isoform of the human glucocorticoid receptor does not act as a physiologically significant repressor”. J. Biol. Chem.272 (42): 26659–64. DOI:10.1074/jbc.272.42.26659. PMID9334248.
Stancato LF, Silverstein AM, Gitler C, Groner B, Pratt WB (April 1996). „Use of the thiol-specific derivatizing agent N-iodoacetyl-3-[125I]iodotyrosine to demonstrate conformational differences between the unbound and hsp90-bound glucocorticoid receptor hormone binding domain”. J. Biol. Chem.271 (15): 8831–6. DOI:10.1074/jbc.271.15.8831. PMID8621522.
Eggert M, Michel J, Schneider S, Bornfleth H, Baniahmad A, Fackelmayer FO, Schmidt S, Renkawitz R (November 1997). „The glucocorticoid receptor is associated with the RNA-binding nuclear matrix protein hnRNP U”. J. Biol. Chem.272 (45): 28471–8. DOI:10.1074/jbc.272.45.28471. PMID9353307.
Zilliacus J, Holter E, Wakui H, Tazawa H, Treuter E, Gustafsson JA (April 2001). „Regulation of glucocorticoid receptor activity by 14--3-3-dependent intracellular relocalization of the corepressor RIP140”. Mol. Endocrinol.15 (4): 501–11. DOI:10.1210/me.15.4.501. PMID11266503.
Subramaniam N, Treuter E, Okret S (June 1999). „Receptor interacting protein RIP140 inhibits both positive and negative gene regulation by glucocorticoids”. J. Biol. Chem.274 (25): 18121–7. DOI:10.1074/jbc.274.25.18121. PMID10364267.
Stevens A, Garside H, Berry A, Waters C, White A, Ray D (May 2003). „Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735”. Mol. Endocrinol.17 (5): 845–59. DOI:10.1210/me.2002-0320. PMID12569182.
Schulz M, Eggert M, Baniahmad A, Dostert A, Heinzel T, Renkawitz R (July 2002). „RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding”. J. Biol. Chem.277 (29): 26238–43. DOI:10.1074/jbc.M203268200. PMID12011091.
Kucera T, Waltner-Law M, Scott DK, Prasad R, Granner DK (July 2002). „A point mutation of the AF2 transactivation domain of the glucocorticoid receptor disrupts its interaction with steroid receptor coactivator 1”. J. Biol. Chem.277 (29): 26098–102. DOI:10.1074/jbc.M204013200. PMID12118039.
Bledsoe RK, Montana VG, Stanley TB, Delves CJ, Apolito CJ, McKee DD, Consler TG, Parks DJ, Stewart EL, Willson TM, Lambert MH, Moore JT, Pearce KH, Xu HE (July 2002). „Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition”. Cell110 (1): 93–105. DOI:10.1016/S0092-8674(02)00817-6. PMID12151000.
Préfontaine, G G; Walther R, Giffin W, Lemieux M E, Pope L, Haché R J (1999). „Selective binding of steroid hormone receptors to octamer transcription factors determines transcriptional synergism at the mouse mammary tumor virus promoter”. J. Biol. Chem. (UNITED STATES) 274 (38): 26713–9. DOI:10.1074/jbc.274.38.26713. ISSN0021-9258. PMID10480874.
Rao, Mira A; Cheng Helen, Quayle Alandra N, Nishitani Hideo, Nelson Colleen C, Rennie Paul S (December 2002). „RanBPM, a nuclear protein that interacts with and regulates transcriptional activity of androgen receptor and glucocorticoid receptor”. J. Biol. Chem. (United States) 277 (50): 48020–7. DOI:10.1074/jbc.M209741200. ISSN0021-9258. PMID12361945.
Caldenhoven E, Liden J, Wissink S, Van de Stolpe A, Raaijmakers J, Koenderman L, Okret S, Gustafsson JA, Van der Saag PT (April 1995). „Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids”. Mol. Endocrinol.9 (4): 401–12. DOI:10.1210/me.9.4.401. PMID7659084.
Li G, Wang S, Gelehrter TD (October 2003). „Identification of glucocorticoid receptor domains involved in transrepression of transforming growth factor-beta action”. J. Biol. Chem.278 (43): 41779–88. DOI:10.1074/jbc.M305350200. PMID12902338.
Zhang Z, Jones S, Hagood JS, Fuentes NL, Fuller GM (December 1997). „STAT3 acts as a co-activator of glucocorticoid receptor signaling”. J. Biol. Chem.272 (49): 30607–10. DOI:10.1074/jbc.272.49.30607. PMID9388192.
Stöcklin E, Wissler M, Gouilleux F, Groner B (October 1996). „Functional interactions between Stat5 and the glucocorticoid receptor”. Nature383 (6602): 726–8. DOI:10.1038/383726a0. PMID8878484.
Makino Y, Yoshikawa N, Okamoto K, Hirota K, Yodoi J, Makino I, Tanaka H (January 1999). „Direct association with thioredoxin allows redox regulation of glucocorticoid receptor function”. J. Biol. Chem.274 (5): 3182–8. DOI:10.1074/jbc.274.5.3182. PMID9915858.
Wakui H, Wright AP, Gustafsson J, Zilliacus J (March 1997). „Interaction of the ligand-activated glucocorticoid receptor with the 14-3-3 eta protein”. J. Biol. Chem.272 (13): 8153–6. DOI:10.1074/jbc.272.13.8153. PMID9079630.
worldcat.org
Préfontaine, G G; Walther R, Giffin W, Lemieux M E, Pope L, Haché R J (1999). „Selective binding of steroid hormone receptors to octamer transcription factors determines transcriptional synergism at the mouse mammary tumor virus promoter”. J. Biol. Chem. (UNITED STATES) 274 (38): 26713–9. DOI:10.1074/jbc.274.38.26713. ISSN0021-9258. PMID10480874.
Rao, Mira A; Cheng Helen, Quayle Alandra N, Nishitani Hideo, Nelson Colleen C, Rennie Paul S (December 2002). „RanBPM, a nuclear protein that interacts with and regulates transcriptional activity of androgen receptor and glucocorticoid receptor”. J. Biol. Chem. (United States) 277 (50): 48020–7. DOI:10.1074/jbc.M209741200. ISSN0021-9258. PMID12361945.
